AU Patent

AU2015230986A1 — Cenicriviroc for the treatment of fibrosis

Assigned to Tobira Therapeutics Inc · Expires 2016-10-13 · 10y expired

What this patent protects

Patent listed against Colcrys.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015230986A1
Jurisdiction
AU
Classification
—
Expires
2016-10-13
Drug substance claim
No
Drug product claim
No
Assignee
Tobira Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.